7 transactions in one company, from January 3, 2025 to January 21, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | IKT | 7 | — | — |
7 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 21 | AAward | 90,000 | $0.00 | —? | 90,000derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 21 | DReturned to issuer | 90,000 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 21 | AAward | 5,834 | $0.00 | —? | 5,834derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 21 | DReturned to issuer | 5,834 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 3 | AAward | 432,853 | $0.00 | —? | 432,853derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 3 | AAward | 235,383 | $0.00 | —? | 235,383derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Garth Lees-RolfeCFODERIV | Jan 3 | AAward | 470,861 | $0.00 | —? | 470,861derivatives |